Colorectal Cancer and Immunotherapy

Thursday
October 7, 2021, 3:55 pm -
4:30 pm
Biomarkers for effective treatment

Watch On Demand

Session Description

While colorectal cancer rates are dropping overall, a worrying trend is emerging: cases are rising in adults between the ages of 20 and 50, who are not screened regularly. Given the necessity of early detection for current treatments, there is a growing need for effective treatments in advanced cases. Immunotherapy for colorectal cancer can be effective, especially in cases where tumors show high microsatellite instability. Join medical oncologist Dr. Van Morris of the University of Texas MD Anderson Cancer Center for a discussion of biomarkers, immunotherapies, and what patients with colorectal cancer need to know. Ask your questions about genetic and genomic testing, treatment options, and other topics in our live Q&A.

Speaker(s)

Van Morris, M.D.

The University of Texas MD Anderson Cancer Center

Dr. Van Morris is an assistant professor in the Department of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston, TX. He completed his fellowship in hematology/oncology at MD Anderson, where he stayed for an additional year as an Advanced Scholar performing translational research on BRAF-mutated metastatic colorectal cancer before joining the faculty. His clinical practice focuses on the treatment of colorectal and anal cancers, and he has written multiple clinical trials which incorporate novel therapeutic approaches involving targeted therapies and immunotherapy. His work has been featured in publications in the New England Journal of Medicine, Lancet Oncology, Cancer Discovery, JAMA Oncology, and the Journal of Clinical Oncology. His work has been supported as a recipient of the ASCO Young investigator Award, NIH/NCI K12 Award, Khalifa Scholar Award, SWOG Hope Foundation Award, and NIH/NCI Colorectal Cancer SPORE Early Career Award.

On-Demand Now Available

We are excited to announce that videos from our 2021 Cancer Research Institute (CRI) Virtual Immunotherapy Patient Summit are now available to view on demand.

The on-demand videos can be found on each session page from the agenda.